130 related articles for article (PubMed ID: 16237768)
1. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy.
Sunada F; Itabashi M; Ohkura H; Okumura T
World J Gastroenterol; 2005 Sep; 11(36):5696-700. PubMed ID: 16237768
[TBL] [Abstract][Full Text] [Related]
2. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.
Miyata H; Doki Y; Shiozaki H; Inoue M; Yano M; Fujiwara Y; Yamamoto H; Nishioka K; Kishi K; Monden M
Clin Cancer Res; 2000 Dec; 6(12):4859-65. PubMed ID: 11156245
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer.
Kishi K; Doki Y; Miyata H; Yano M; Yasuda T; Monden M
Br J Surg; 2002 May; 89(5):597-603. PubMed ID: 11972550
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
Noda M; Okumura H; Uchikado Y; Omoto I; Sasaki K; Kita Y; Mori S; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Maemura K; Natsugoe S
Ann Surg Oncol; 2018 Feb; 25(2):449-455. PubMed ID: 29188501
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
Samejima R; Kitajima Y; Yunotani S; Miyazaki K
Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
[TBL] [Abstract][Full Text] [Related]
8. Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
Nakamura T; Hayashi K; Ota M; Ide H; Takasaki K; Mitsuhashi M
Dis Esophagus; 2004; 17(4):315-21. PubMed ID: 15569370
[TBL] [Abstract][Full Text] [Related]
9. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy.
Michel P; Magois K; Robert V; Chiron A; Lepessot F; Bodenant C; Roque I; Seng SK; Frebourg T; Paillot B
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):379-85. PubMed ID: 12243811
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy.
Okumura H; Uchikado Y; Setoyama T; Matsumoto M; Owaki T; Ishigami S; Natsugoe S
Surg Today; 2014 Mar; 44(3):421-8. PubMed ID: 23605218
[TBL] [Abstract][Full Text] [Related]
13. Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer.
Ikeguchi M; Maeta M; Kaibara N
Int J Mol Med; 2001 Apr; 7(4):413-7. PubMed ID: 11254884
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Tamotsu K; Okumura H; Uchikado Y; Kita Y; Sasaki K; Omoto I; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Natsugoe S
BMC Cancer; 2015 Apr; 15():323. PubMed ID: 25924824
[TBL] [Abstract][Full Text] [Related]
15. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.
Gombodorj N; Yokobori T; Tanaka N; Suzuki S; Kuriyama K; Kumakura Y; Yoshida T; Sakai M; Sohda M; Baatar S; Miyazaki T; Nishiyama M; Shirabe K; Kuwano H
J Surg Oncol; 2018 Jul; 118(1):101-108. PubMed ID: 30098297
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus.
Puglisi F; Di Loreto C; Panizzo R; Avellini C; Fongione S; Cacitti V; Beltrami CA
J Clin Pathol; 1996 Jun; 49(6):456-9. PubMed ID: 8763257
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma.
Wang M; Zhu XY; Wang L; Lin Y
Cancer Biother Radiopharm; 2015 Apr; 30(3):139-45. PubMed ID: 25775393
[TBL] [Abstract][Full Text] [Related]
18. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
19. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
Shimada Y; Watanabe G; Yamasaki S; Maeda M; Kawabe A; Kaganoi JI; Itami A; Fukumoto M; Kanda Y; Imamura M
Eur J Cancer; 2000 May; 36(8):987-93. PubMed ID: 10885602
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
Kii T; Takiuchi H; Kawabe S; Gotoh M; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
Jpn J Clin Oncol; 2007 Aug; 37(8):583-9. PubMed ID: 17709606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
